| Literature DB >> 15057674 |
G Schernthaner1, H-P Kopp, S Ristic, B Muzyka, L Peter, G Mitteregger.
Abstract
OBJECTIVE: Patients with type 2 diabetes most frequently use injections of premixed insulin formulations twice daily, but intensified insulin therapy may provide better control. This study was designed to compare metabolic control with three daily injections of Humalog Mix50 or premixed human insulin 30/70 (30 % regular/70 % NPH) twice daily in accordance with normal prescription practice. RESEARCH DESIGN AND METHODS: The study cohort of 40 patients with type 2 diabetes used a two-way, crossover design. Patients were randomized to either Mix50 at each main meal or human insulin 30/70 at breakfast and dinner for 3 months, followed by the alternate treatment for 3 months. Blood glucose was measured by the patients at baseline and at the end of each treatment sequence. No significant carryover effects were observed, so treatment sequences were combined and data analyzed by unpaired t-tests.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15057674 DOI: 10.1055/s-2004-814345
Source DB: PubMed Journal: Horm Metab Res ISSN: 0018-5043 Impact factor: 2.936